{{Rsnum
|rsid=11587873
|Chromosome=1
|Orientation=plus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=DPYD
|position=97187514
|Gene_s=DPYD,DPYD-AS1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 57.1 | 38.4 | 4.5
| HCB | 90.5 | 9.5 | 0.0
| JPT | 92.0 | 7.1 | 0.9
| YRI | 91.1 | 8.9 | 0.0
| ASW | 80.7 | 19.3 | 0.0
| CHB | 90.5 | 9.5 | 0.0
| CHD | 93.6 | 5.5 | 0.9
| GIH | 61.4 | 34.7 | 4.0
| LWK | 85.3 | 13.8 | 0.9
| MEX | 72.4 | 27.6 | 0.0
| MKK | 87.2 | 12.2 | 0.6
| TSI | 58.8 | 33.3 | 7.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=25066213
|Title=Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}